Latest Capital Management News

IPB Petroleum advances its key Browse Basin assets with ongoing drilling discussions and a strategic board appointment, while maintaining a solid cash position.

Salter Brothers Emerging Companies Limited has announced a further 12-month extension of its on-market share buy-back program, allowing the company to repurchase up to 8.45 million shares to maintain capital management flexibility and enhance shareholder value.

Highfield Resources has secured a A$10 million convertible note investment from existing strategic shareholders following the collapse of a proposed strategic transaction with China Minmetals and Yankuang Energy. The company also received renewed institutional backing from the Government of Navarra for its flagship Muga Potash Project.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Fortescue Metals Group kicked off FY26 with record iron ore shipments and strengthened its decarbonisation strategy through new partnerships and a $2 billion Renminbi loan.

Brambles Limited reported robust FY25 financial results and sustainability achievements, highlighting a $1 billion free cash flow milestone and ambitious 2030 regenerative targets at its 2025 AGM.

Australian Clinical Labs has announced a 12-month on-market share buy-back program targeting up to 10% of its shares, aiming to enhance shareholder returns without compromising its financial strength.

Bellevue Gold Limited reported a robust September quarter with production and sales exceeding expectations, alongside a pioneering net zero emissions milestone. The company is well positioned for growth in FY26 with strategic leadership appointments and improved operational efficiencies.

Regis Resources reported a solid September quarter with 90.4koz gold production and a $158 million increase in cash and bullion. Key underground projects at Garden Well Main and Rosemont Stage 3 began ore production, supporting steady FY26 guidance.

Sigma Healthcare’s 2025 AGM reveals a robust year of transformation post-merger with Chemist Warehouse, highlighted by upgraded synergy targets and impressive financial gains.

Sigma Healthcare’s transformative merger with Chemist Warehouse has propelled the company into Australia’s top 20 ASX firms, with FY25 results exceeding expectations and synergy targets nearly doubling.

Michael Hill International reported steady FY25 financials amid challenging markets, with early FY26 trading showing promising margin improvements and mixed sales across regions.